ArticleBMJ open2025

STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's disease.

Gesine Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.